BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12902477)

  • 1. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
    Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
    J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Chiba S; Nieda M; Azuma T; Ishihara S; Shibata Y; Juji T; Hirai H
    J Immunol; 2002 Apr; 168(7):3140-4. PubMed ID: 11907064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Nieda M; Koezuka Y; Nicol A; Porcelli SA; Ishikawa Y; Tadokoro K; Hirai H; Juji T
    J Immunol; 2000 May; 164(9):4458-64. PubMed ID: 10779745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
    van der Vliet HJ; von Blomberg BM; Hazenberg MD; Nishi N; Otto SA; van Benthem BH; Prins M; Claessen FA; van den Eertwegh AJ; Giaccone G; Miedema F; Scheper RJ; Pinedo HM
    J Immunol; 2002 Feb; 168(3):1490-5. PubMed ID: 11801694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains.
    Matsuura A; Kinebuchi M; Chen HZ; Katabami S; Shimizu T; Hashimoto Y; Kikuchi K; Sato N
    J Immunol; 2000 Mar; 164(6):3140-8. PubMed ID: 10706704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells.
    Gansuvd B; Hubbard WJ; Hutchings A; Thomas FT; Goodwin J; Wilson SB; Exley MA; Thomas JM
    J Immunol; 2003 Sep; 171(6):2904-11. PubMed ID: 12960313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT lymphocyte ontogeny and function are impaired in low antibody-producer Biozzi mice: gene mapping in the interval-specific congenic strains raised for immunomodulatory genes.
    Araujo LM; Puel A; Gouarin C; Hameg A; Mevel JC; Koezuka Y; Bach JF; Mouton D; Herbelin A
    Int Immunol; 2000 Nov; 12(11):1613-22. PubMed ID: 11058581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.
    Nishi N; van der Vliet HJ; Koezuka Y; von Blomberg BM; Scheper RJ; Pinedo HM; Giaccone G
    Hum Immunol; 2000 Apr; 61(4):357-65. PubMed ID: 10715513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
    Harada Y; Imataki O; Heike Y; Kawai H; Shimosaka A; Mori S; Kami M; Tanosaki R; Ikarashi Y; Iizuka A; Yoshida M; Wakasugi H; Saito S; Takaue Y; Takei M; Kakizoe T
    J Immunother; 2005; 28(4):314-21. PubMed ID: 16000949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
    Molling JW; Kölgen W; van der Vliet HJ; Boomsma MF; Kruizenga H; Smorenburg CH; Molenkamp BG; Langendijk JA; Leemans CR; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
    Int J Cancer; 2005 Aug; 116(1):87-93. PubMed ID: 15756674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells.
    Crowe NY; Uldrich AP; Kyparissoudis K; Hammond KJ; Hayakawa Y; Sidobre S; Keating R; Kronenberg M; Smyth MJ; Godfrey DI
    J Immunol; 2003 Oct; 171(8):4020-7. PubMed ID: 14530322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Valpha24+CD161+ natural killer T cells and invariant TCRAV24-AJ18 transcripts in atopic and non-atopic individuals.
    Prell C; Konstantopoulos N; Heinzelmann B; Frankenberger B; Reinhardt D; Schendel DJ; Krauss-Etschmann S
    Immunobiology; 2003; 208(4):367-80. PubMed ID: 14748510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.